levothyroxine sodium berlin-chemie 25 mikrogrami tabletes
berlin-chemie ag, germany - levotiroksīna nātrija sāls - tablete - 25 μg
orserdu
stemline therapeutics b.v. - elacestrant - krūts audzējs - endokrīnā terapija - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
iclusig
incyte biosciences distribution b.v. - ponatinibs - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. skatīt nodaļas 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.
laif 612 mg apvalkotās tabletes
uab bayer, lithuania - hyperici herb sausā ekstrakta - apvalkotās tabletes - 612 mg
ciqorin 10 mg mīkstās kapsulas
teva pharma b.v., netherlands - ciklosporīns - mīkstās kapsulas - 10 mg
ciqorin 25 mg mīkstās kapsulas
teva pharma b.v., netherlands - ciklosporīns - kapsula, mīkstā - 25 mg
ciqorin 50 mg mīkstās kapsulas
teva pharma b.v., netherlands - ciklosporīns - kapsula, mīkstā - 50 mg
ciqorin 100 mg mīkstās kapsulas
teva pharma b.v., netherlands - ciklosporīns - mīkstās kapsulas - 100 mg
sunitinib g.l. pharma 12,5 mg cietās kapsulas
g.l. pharma gmbh, austria - sunitinibs - kapsula, cietā - 12,5 mg
sunitinib g.l. pharma 25 mg cietās kapsulas
g.l. pharma gmbh, austria - sunitinibs - kapsula, cietā - 25 mg